Source: Research Seminar 2021 – Unravelling severe exacerbations of COPD – CICERO an ERS CRC
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Quint (London, United Kingdom). How can real-world data be used to improve outcomes?. Research Seminar 2021 – Unravelling severe exacerbations of COPD – CICERO an ERS CRC

Member's Comments

No comment yet.

Related content which might interest you: Using big data to change healthcare: improving quality of care with routine data Source: International Congress 2016 – Primary Care Day: challenging times III Year: 2016 From clinical trials to real-world data: New dimensions of patient benefits Source: International Congress 2015 – IgE-mediated asthma: New revelations and future insights Year: 2015 How do differences in the definition of good quality care affect classification of hospital performance? Source: Virtual Congress 2020 – New and integrated tools for respiratory diagnosis and care Year: 2020 Using quality improvement project to improve childhood asthma outcomes in low resource setting Source: Virtual Congress 2021 – Early-life infections, wheezing and asthma Year: 2021 Can telemedicine help in improving SDB outcomes? Source: Sleep and Breathing Conference 2017 Year: 2017 Translating trials to clinical practice: results ²more real than real life itself²¹ Source: Annual Congress 2007 - Smoking cessation Year: 2007 Defining successful NIV setup: data from a real-life cohort Source: Virtual Congress 2021 – Home mechanical ventilation: organisation and outcomes Year: 2021 How do we know what works? Clinical trial end-points and quality of life assessment Source: Eur Respir Monogr 2018; 81: 99-132 Year: 2018 Does 7-day working improve outcomes for COPD? Source: International Congress 2019 – COPD: epidemiology and spirometry Year: 2019 Do the current endpoints in IPF clinical trials allow good regulatory decisions to be made? Source: International Congress 2014 – Ceremony for the ERS Rare Pulmonary Disease Research Award 2014 followed by the symposium "Challenges in endpoints for rare lung diseases" Year: 2014 Does the endotype-driven approach translate into improved quality of life? Source: Virtual Congress 2020 – Precision endotyping of asthma: time for action Year: 2020 How to use monitoring data to make wise clinical decisions Source: International Congress 2015 – PG3 Cardiorespiratory monitoring in critically ill patients Year: 2015 How to improve compliance with CPAP/NIV? Source: ERS Course 2017 - Paediatric noninvasive ventilation Year: 2017 Alpha-1-antitrypsine dephiciency. Can we improve prognosis? Source: Annual Congress 2008 - Pulmonary infections in children - rare but important aspects Year: 2008 Asthma quality of life in clinical trials - can we combine data from different countries? Source: Eur Respir J 2001; 18: Suppl. 33, 4s Year: 2001 Asthma program characteristics associated with clinical health outcomes: examining practice in the field to increase chances for success Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology II Year: 2007 The use of an electronic health record improves asthma clinical outcomes Source: Annual Congress 2010 - Management of airway disease Year: 2010 What requirements should a biomarker meet to be used in the clinical and epidemiological setting? Source: Annual Congress 2008 - Biomarkers in COPD - application in clinical and epidemiological studies Year: 2008 Efficiency of different strategies of asthma control achievement in real clinical practice Source: Annual Congress 2011 - Asthma: control and treatment Year: 2011 Economic impact analysis of a tele-medicine program to improve the quality of apirometry in primary care Source: Annual Congress 2012 - Going with the flow: assessment and evaluation of airway function and its role in patient management Year: 2012